Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,533 | 916 | 1,153 | 1,293 | 456 |
| Receivables | 980 | 876 | 1,071 | 1,460 | 892 |
| Inventories | 576 | 494 | 519 | 458 | 544 |
| Other current assets | 153 | 173 | 137 | 160 | 156 |
| TOTAL | $4,242 | $2,459 | $2,880 | $3,371 | $2,048 |
| Non-Current Assets | |||||
| PPE Net | 1,347 | 1,388 | 1,436 | 1,469 | 1,510 |
| Intangibles | 805 | 828 | 829 | 745 | 778 |
| Other Non-Current Assets | 1,019 | 1,004 | 989 | 955 | 1,400 |
| TOTAL | $3,171 | $3,220 | $3,254 | $3,169 | $3,688 |
| Total Assets | $7,413 | $5,679 | $6,134 | $6,540 | $5,736 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,105 | 2,265 | 2,379 | 2,527 | 1,453 |
| Accounts payable and accrued liabilities | 418 | 664 | 626 | 792 | 467 |
| Accrued Expenses | 1,450 | 1,479 | 1,432 | 1,038 | 924 |
| Other current liabilities | N/A | 340 | N/A | N/A | N/A |
| TOTAL | $6,297 | $5,019 | $4,721 | $4,662 | $3,149 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,475 | 1,459 | 1,116 | 891 | 774 |
| Deferred Revenues | 208 | 143 | 143 | 93 | 93 |
| Other Non-Current Liabilities | -2,381 | -2,275 | -2,319 | -2,307 | -2,367 |
| TOTAL | $3,452 | $3,262 | $2,980 | $2,331 | $2,286 |
| Total Liabilities | $9,750 | $8,281 | $7,701 | $6,993 | $5,434 |
| Shareholders' Equity | |||||
| Common Shares | 23,133 | 22,159 | 22,156 | 21,974 | 21,974 |
| Retained earnings | -35,219 | -34,319 | -33,210 | -31,941 | -30,419 |
| Other shareholders' equity | 0 | 0 | 1,662 | 1,549 | 1,549 |
| TOTAL | $-4,718 | $-4,878 | $-3,886 | $-2,760 | $-2,066 |
| Total Liabilities And Equity | $5,032 | $3,404 | $3,815 | $4,233 | $3,369 |